Patient characteristics
| Characteristic . | N . |
|---|---|
| Patients, no | 23 |
| Median age, y (range) | 71 (61-79) |
| Sex ratio, M/F | 14/9 |
| FAB category, n (%) | |
| M0 | 5 (22%) |
| M1 | 4 (17%) |
| M2 | 5 (22%) |
| M4 | 1 (4%) |
| M5 | 3 (13%) |
| M6 | 2 (8.6%) |
| M7 | 1 (4%) |
| Unclassified | 1 (4%) |
| Cytogenetics, n (%) | |
| Normal | 12 (52%) |
| Complex | 3 (13%) |
| Chromosome 5/7 abnormalities | 3 (13%) |
| Other | 5 (22%) |
| Induction courses for CR | |
| 1, n (%) | 20 (87%) |
| 2, n (%) | 3 (13%) |
| Consolidation courses, n, median (range) | 2 (1-6) |
| Interval diagnosis inclusion, mo, median (range) | 5.8 (3.8-13) |
| Interval CR inclusion, mo, median (range) | 4.6 (0.4-11.9) |
| Characteristic . | N . |
|---|---|
| Patients, no | 23 |
| Median age, y (range) | 71 (61-79) |
| Sex ratio, M/F | 14/9 |
| FAB category, n (%) | |
| M0 | 5 (22%) |
| M1 | 4 (17%) |
| M2 | 5 (22%) |
| M4 | 1 (4%) |
| M5 | 3 (13%) |
| M6 | 2 (8.6%) |
| M7 | 1 (4%) |
| Unclassified | 1 (4%) |
| Cytogenetics, n (%) | |
| Normal | 12 (52%) |
| Complex | 3 (13%) |
| Chromosome 5/7 abnormalities | 3 (13%) |
| Other | 5 (22%) |
| Induction courses for CR | |
| 1, n (%) | 20 (87%) |
| 2, n (%) | 3 (13%) |
| Consolidation courses, n, median (range) | 2 (1-6) |
| Interval diagnosis inclusion, mo, median (range) | 5.8 (3.8-13) |
| Interval CR inclusion, mo, median (range) | 4.6 (0.4-11.9) |